Journal of Chemical Technology & Biotechnology 2013

1 papers

Top Research Directions

The 4 research directions with Journal of Chemical Technology & Biotechnology 2013 papers, ranked by paper count. Share is the fraction of the edition’s papers in the direction.

#DirectionPapersShare
1Evolutionary Search in Non-Differentiable Parameter Spaces1100.0%
2Monotonic Progress Retention in Evolutionary Search1100.0%
3Probabilistic Risk Assessment via Monte Carlo Simulation1100.0%
4Tracking Moving Optima over Shifting Landscapes1100.0%

Download all directions as CSV

Institutions

Institutions credited by Journal of Chemical Technology & Biotechnology 2013 papers: a paper credits every institution named in its affiliations, once. 1 institutions share 1 credited papers.

#InstitutionPapersShare
1University College London 1100.0%

Download all institutions as CSV

About this data

Papers. Journal of Chemical Technology & Biotechnology 2013 lists 1 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 1 papers (100.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Journal of Chemical Technology & Biotechnology 2013”, https://lacuna.tiptreesystems.com/venue/journal-of-chemical-technology-biotechnology/2013.

Impactful Papers

Papers from Journal of Chemical Technology & Biotechnology 2013 that shaped research clusters.

Influential

Papers

Title
Closed‐loop optimization of chromatography column sizing strategies in biopharmaceutical manufacture